Halaman 2 - Malformasi arteriovenosa Dokter Terbaik di Istambul - TOP-22 dokter

Bedah Saraf

Bidang Studi dan Minat

• Spina Bifida,

• Massa Lumbar,

• Tumor,

• Meningomielokel,

• Penyakit Neurologis,

• Hernia Diskus Servikal,

• Penyakit Otak,

• Diskus Hernia

• Hernia Leher

• Stenosis Kanal Tulang Belakang

• Spondilolistesis (Perpindahan Pinggang)

• Tumor Otak

• Tumor Sumsum Tulang Belakang

• Fraktur Tulang Belakang

• Perdarahan Serebral

• Aneurisma Otak

• Hidrosefalus

• Sindrom Carpal Tunnel

Pendidikan

• Pelatihan Spesialisasi Bedah Saraf Klinik Bedah Saraf University of Wisconsin 2017,

Madison/AS

• Pelatihan Spesialisasi Bedah Otak dan Saraf Rumah Sakit Penyakit Mental dan Neurologis Bakırköy

2014, Istanbul/Turki

• Pelatihan Spesialisasi Dokter Medis Fakultas Kedokteran Universitas Mersin 2007,

Mersin/Turki

Karier

• Rumah Sakit Pelatihan dan Penelitian Kanuni Sultan Süleyman Istanbul 2014-2021, Istanbul/Turki

• Rumah Sakit Jiwa Bakırköy Istanbul 2008-2014, Istanbul/Turki

• Rumah Sakit Negeri Çorlu 2007-2008, Çorlu/Turki

Publikasi: Üçer, M. (2021). Pendekatan Minimal Invasif Terhadap Perbaikan Pars Langsung Perkutan: Studi Observasi. World Neurosurgery, 146, e1301-e1306.

Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.

He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.

His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.